On October 14, 2025, bioAffinity Technologies, Inc. confirmed it is compliant with Nasdaq's listing rules after receiving a letter from the Nasdaq Hearings Panel; however, it will be monitored for one year to ensure continued compliance.
AI Assistant
BIOAFFINITY TECHNOLOGIES INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.